Search results
- 1.9800Add to watchlist+0.1700 (+9.39%)At close: Fri. May 17, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Pre-Market Time
- Open1.8300High2.0400Low1.8300
- Mkt Cap17.07MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close1.810052 Wk. Low1.020052 Wk. High19.2000
Related stocks
Long-term IBIO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050. Based on our analysis about iBio Inc financial reports and earnings history, iBio Inc (IBIO) stock could reach $19.30 by 2030, $15.73 by 2040 and $40.53 by 2050. See the projected annual prices until 2050 of the iBio Inc stock below:
6 days ago · Find the latest iBio, Inc. (IBIO) stock quote, history, news and other vital information to help you with your stock trading and investing.
Sep 27, 2021 · A high-level overview of iBio, Inc. (IBIO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Tonix Pharmaceuticals Holding Corp.
- Biotechnology
- 103
- 15.29M
2 days ago · About IBIO. iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel.
People also ask
What will IBio Inc stock price rise this year?
Is IBio's stock under the radar?
Is IBio Inc's future price predictability good or bad?
Is there enough analysis data for IBio?
Get the latest Ibio Inc (IBIO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
View iBio, Inc. IBIO stock quote prices, financial information, real-time forecasts, and company news from CNN.
3 days ago · iBio, Inc., a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel.